569 related articles for article (PubMed ID: 10670640)
1. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
2. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration.
Motoyama K; Arima T; Lehmann M; Flye MW
Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125
[TBL] [Abstract][Full Text] [Related]
4. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
[TBL] [Abstract][Full Text] [Related]
5. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
[TBL] [Abstract][Full Text] [Related]
6. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
7. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
[TBL] [Abstract][Full Text] [Related]
8. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
Yu S; Nakafusa Y; Flye MW
Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
[TBL] [Abstract][Full Text] [Related]
9. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
Arima T; Goss JA; Walp LA; Flye MW
Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
[TBL] [Abstract][Full Text] [Related]
10. Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1992 Oct; 216(4):409-14; discussion 414-6. PubMed ID: 1417190
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis of gadolinium chloride abrogation of the systemic tolerance induced by portal venous administration of ultraviolet B-irradiated donor cells.
Yu S; Nakafusa Y; Flye MW
Transplantation; 1997 Dec; 64(12):1684-8. PubMed ID: 9422402
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
13. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
14. Prevention by thymectomy of tolerance induced by intrathymic injection of donor splenocytes.
Nakafusa Y; Goss JA; Flye MW
Surgery; 1993 Aug; 114(2):183-9; discussion 189-90. PubMed ID: 8342124
[TBL] [Abstract][Full Text] [Related]
15. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen.
Motoyama K; Lehmann M; Flye MW
Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552
[No Abstract] [Full Text] [Related]
16. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
17. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
[TBL] [Abstract][Full Text] [Related]
19. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody.
Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ
Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183
[TBL] [Abstract][Full Text] [Related]
20. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
